INCR Stock Analysis: Buy, Sell, or Hold?
INCR - Intercure Ltd. Ordinary Shares
$0.85
0.03 (3.65%)
▲
5d:
+3.63%
30d:
+10.36%
90d:
-2.87%
BUY
MODERATE Confidence
Analysis Updated: May 18, 2026 12:00 AM ET
Earnings: May 20, 2026
1d
Get Alerted When INCR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: INCR shows positive signals but monitor for confirmation. Moderate conviction.
💡 BUY OPPORTUNITY: INCR shows positive signals but monitor for confirmation. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: INCR is currently trading at $0.85, which is considered slightly high relative to its 30-day fair value range of $0.77 to $0.87.
Technical Outlook: Technically, INCR is in a downtrend. Immediate support is located at $0.81, while resistance sits at $0.90. The stock is showing strong short-term momentum, up 3.6% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $33.56 (+3992.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, INCR is in a downtrend. Immediate support is located at $0.81, while resistance sits at $0.90. The stock is showing strong short-term momentum, up 3.6% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $33.56 (+3992.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$0.77 -
$0.87
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.1%
All Signals
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.6%)
- BULLISH: Trading 3992.7% below Wall St target ($33.56)
Trading Range Analysis
30-Day Trading Range
$0.77 -
$0.87
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$0.81
Resistance Level
$0.90
Current Trend
Downtrend
Technical data as of
May 18, 2026
Fundamental Context
Forward P/E (Next Year Est.)
6.18
Wall Street Target
$33.56
(+3992.7%)
Revenue Growth (YoY)
23.9%
Earnings Growth (YoY)
-84.7%
Profit Margin
-13.2%
Share & Embed Analysis
Last updated: May 18, 2026 1:49 PM ET
Data refreshes hourly during market hours. Next update: 2:49 PM
Data refreshes hourly during market hours. Next update: 2:49 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INCR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$191 | 55 HOLD |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$131 | 54 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$104 | 60 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$22 | 58 HOLD |
|
TEVA
Teva Pharma Industries L… |
STRONG BUY
11 analysts |
$40 | 58 HOLD |
